A study by Li et al in 2017 [3] showed that APRI >2 cannot be used to represent cirrhosis especially in HBeAg negative patients who have ALT values ≤2 ULN (upper limit normal) as this greatly underestimates the number of cases with cirrhosis. The gene discussed is GPT; the disease is Cirrhosis.